Read More Analyst Ratings Initiation News Price Target RBC Capital Initiates Coverage On Edgewise Therapeutics with Outperform Rating, Announces Price Target of $31 By Benzinga Newsdesk Today, 3:04 AM RBC Capital initiates coverage on Edgewise Therapeutics (NASDAQ:EWTX) with a Outperform rating and announces Price Target of $31. EWTX
Read More Intraday Update Markets Movers 12 Consumer Discretionary Stocks Moving In Wednesday’s Intraday Session By Benzinga Insights Today, 3:04 AM BBIG
Read More Earnings News Colfax Q4 EPS $0.59 Beats $0.57 Estimate, Sales $1.02B Beat $1.01B Estimate By Bill Haddad Today, 3:04 AM Colfax (NYSE:CFX) reported quarterly earnings of $0.59 per share which beat the analyst consensus estimate of $0.57 by 3.51 percent. This is a 15.69 percent increase over earnings of $0.51 per share from the same period CFX
Read More Analyst Ratings Initiation News Price Target Stifel Initiates Coverage On Leslies with Buy Rating, Announces Price Target of $28 By vishwanath@benzinga.com Today, 3:04 AM Stifel analyst W. Andrew Carter initiates coverage on Leslies (NASDAQ:LESL) with a Buy rating and announces Price Target of $28. LESL